Increased endogenous levels of Apaf-1 protein have been observed in human brain tumors, a consequence of E2F1 transcriptional activity[40], and in Huntington’s disease (HD) and its mouse and fly models[41]. This evidence concerns the gene E2F1 and Huntington disease.